BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 15148253)

  • 1. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
    Ceglia I; Acconcia S; Fracasso C; Colovic M; Caccia S; Invernizzi RW
    Br J Pharmacol; 2004 Jun; 142(3):469-78. PubMed ID: 15148253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.
    Casanovas JM; Lésourd M; Artigas F
    Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of imipramine on extracellular serotonin and noradrenaline concentrations in ACTH-treated rats.
    Kitamura Y; Akiyama K; Hashimoto S; Kitagawa K; Kawasaki H; Shibata K; Shinomiya K; Suemaru K; Araki H; Sendo T; Gomita Y
    Eur J Pharmacol; 2007 Jul; 566(1-3):113-6. PubMed ID: 17459373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.
    Sato M; Ago Y; Koda K; Nakamura S; Kawasaki T; Baba A; Matsuda T
    Eur J Pharmacol; 2007 Mar; 559(2-3):155-60. PubMed ID: 17258195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.
    Nakayama K; Sakurai T; Katsu H
    Brain Res Bull; 2004 Apr; 63(3):237-41. PubMed ID: 15145142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postnatal stress affects 5-HT1A receptor function in the medial prefrontal cortex in adult rats.
    Matsuzaki H; Izumi T; Matsumoto M; Togashi H; Yamaguchi T; Yoshida T; Watanabe M; Yoshioka M
    Eur J Pharmacol; 2009 Aug; 615(1-3):76-82. PubMed ID: 19470384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
    Iskra-Jopa J; Gołembiowska K; Dziubina A; Cybulski M; Duszyńska B; Chilmonczyk Z
    J Pharm Pharmacol; 2005 Feb; 57(2):205-11. PubMed ID: 15720784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.
    Millan MJ; Gobert A; Roux S; Porsolt R; Meneses A; Carli M; Di Cara B; Jaffard R; Rivet JM; Lestage P; Mocaer E; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2004 Oct; 311(1):190-203. PubMed ID: 15146031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
    Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
    J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
    Nair SG; Gudelsky GA
    Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nelumbinis Semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like symptom.
    Jang CG; Kang M; Cho JH; Lee SB; Kim H; Park S; Lee J; Park SK; Hong M; Shin MK; Shim IS; Bae H
    Arch Pharm Res; 2004 Oct; 27(10):1065-72. PubMed ID: 15554266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
    Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
    Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
    Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications.
    Ba M; Kong M; Ma G; Yang H; Lu G; Chen S; Liu Z
    Brain Res; 2007 Jan; 1127(1):177-84. PubMed ID: 17113046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
    J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselectivity of 8-OH-DPAT toward the serotonin 5-HT1A receptor: biochemical and molecular modeling study.
    Dabrowska J; Brylinski M
    Biochem Pharmacol; 2006 Aug; 72(4):498-511. PubMed ID: 16796994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo.
    Beyer CE; Ghavami A; Lin Q; Sung A; Rhodes KJ; Dawson LA; Schechter LE; Young KH
    Brain Res; 2004 Oct; 1022(1-2):214-20. PubMed ID: 15353231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.